Related Experiment Videos
[Anaphylactic shock caused by pancuronium and vecuronium]
Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1985
Summary
Anaphylactic shock from vecuronium occurred in a patient previously sensitized by pancuronium. This highlights cross-allergies between neuromuscular blocking agents and the need for thorough allergy testing.
Area of Science:
- Anesthesiology
- Immunology
- Pharmacology
Background:
- Anaphylactic shock is a severe, life-threatening allergic reaction.
- Neuromuscular blocking agents (NMBAs) are commonly used during general anesthesia.
- Previous sensitization to one NMBA can lead to reactions with others.
Observation:
- A patient experienced anaphylactic shock during general anesthesia due to vecuronium.
- This patient had a prior history of anaphylactic shock caused by pancuronium.
Findings:
- This case represents the first documented instance of anaphylactic shock specifically linked to vecuronium bromide.
- The patient's reaction suggests a potential cross-allergy between pancuronium and vecuronium.
- Antihistamine premedication showed limited efficacy in preventing the reaction.
Implications:
- Highlights the critical need for comprehensive immuno-allergological investigations in patients with a history of anaphylaxis to NMBAs.
- Emphasizes the potential for cross-reactivity among different NMBAs, even with novel agents.
- Suggests that sensitization to one NMBA can predispose patients to reactions with structurally related or even novel NMBAs.